Show simple item record

dc.contributor.authorBesada, Emilio
dc.date.accessioned2016-03-15T10:09:52Z
dc.date.available2016-03-15T10:09:52Z
dc.date.issued2015
dc.identifier.citationRevmatologi BestPractice 2015, 7(24):9-11en_US
dc.identifier.cristinIDFRIDAID 1267102
dc.identifier.urihttps://hdl.handle.net/10037/8952
dc.identifier.urnURN:NBN:no-uit_munin_8521
dc.language.isonoben_US
dc.publisherBestPracticeen_US
dc.rights.accessRightsopenAccess
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Reumatologi: 759en_US
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Rheumatology: 759en_US
dc.titleEr det forskjell på subkutan og intravenøs tocilizumab ved behandling av revmatoid artritt?en_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US


File(s) in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record